Gene Expression Profiling and Mutation Analysis Can Aid Treatment Decision Making in Aggressive B Cell Lymphoma Patients

Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_10
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Patients' Decision-Making, Experiences and Preferences Regarding Pixantrone Treatment in Relapsed Aggressive B-Cell Lymphoma: Research Protocol for a Longitudinal Qualitative Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Molecular Genetics of Aggressive B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Cell‐of‐origin Determined by Both Gene Expression Profiling and Immunohistochemistry Is the Strongest Predictor of Survival in Patients With Diffuse Large B‐cell Lymphoma

American Journal of Hematology
Hematology
2019English

Differential Gene Expression Profiling of Aggressive and Nonaggressive Follicular Carcinomas

Human Pathology
Forensic MedicinePathology
2011English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma

American Journal of Hematology
Hematology
2018English

Enhancing Treatment Decision-Making: Pilot Study of a Treatment Decision Aid in Stage IV Non-Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2008English

Algorithm Can Aid in End-Of-Life Decision-Making for Unrepresented Residents

Caring for the Ages
2019English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B- And T-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Role of Up-Front Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Aggressive Adult T-Cell Leukemia-Lymphoma: A Decision Analysis

Bone Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy